Last updated on January 2019

QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant


Brief description of study

The purpose of this trial is to evaluate the reduction in incidence and severity of delayed graft function with kidney allografts from donors >45 years after brain death (DBD).

Detailed Study Description

This is a Phase 3 randomized, placebo-controlled, double-blind, multi-center trial stratified by donor age and by region to evaluate the reduction in incidence and severity of delayed graft function with kidney allografts from DBD donors who were at least 45 years of age.

Clinical Study Identifier: NCT02610296

Contact Investigators or Research Sites near you

Start Over

Annemarie Weeber

Leids Universitair Medisch Centrum
Leiden, Netherlands
9.99miles

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.